Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if tobramycin inhalation powder (TIP) can reduce
the amount of Burkholderia Cepacia Complex (BCC) species - type of bacteria, in the sputum of
cystic fibrosis patient.
Phase:
Phase 1
Details
Lead Sponsor:
St. Michael's Hospital, Toronto Unity Health Toronto